Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide in Stage 1 Type 1 Diabetes
NCT07430332Phase 2Not yet recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Sep 2027
- Primary completion
- Jun 2029
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of semaglutide in type 1 diabetes mellitus (T1D), sponsored by Cincinnati Children's Hospital Medical Center. Planned start Sep 2027; status: not yet recruiting.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07430332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07430332.